FTC Asks 1st Circ. To Reverse Momenta Antitrust Win
The Federal Trade Commission on Monday told the First Circuit that a lower court had incorrectly granted immunity to Momenta Pharmaceuticals Inc. from an antitrust suit by Amphastar Pharmaceuticals Inc. and...To view the full article, register now.
Already a subscriber? Click here to view full article